shot-button
Banner Banner
Home > Brand Media News > Oncohiv Paves the Way for Normalizing Generic Drugs in Indian Healthcare

Oncohiv Paves the Way for Normalizing Generic Drugs in Indian Healthcare

Updated on: 23 February,2022 12:27 PM IST  |  Mumbai
BrandMedia | brandmedia@mid-day.com

.

Oncohiv Paves the Way for Normalizing Generic Drugs in Indian Healthcare

Representational Image

In a developing country, generic medication has a deeply embedded role in supporting the public system due to its affordability and easy availability. In 2017, Prime Minister Narendra Modi declared that the administration has proposed to move a law to guarantee that specialists recommend prescriptions by their generic names as it were. With this move, the Government wanted to challenge the nexus between the branded drug manufacturers and the doctors while bringing down the price of the life-saving drugs simultaneously.


Oncohiv is a mass distributor of generic drugs and OTC that seeks to assist the Indian Government In its mission of making the healthcare sector more affordable for the common mass. The major concern for the Indian Government is overseeing the manufacturing of generic drugs to ensure that the manufacturing processes are aligned to the global manufacturing processes. Without the quality control regulations in place, it will be hard for generic drugs to win the trust of the doctors who will recommend them to their patients. Oncohiv is a distributor that is managed by top industrial professionals who keep a constant eye on manufacturing and quality control to meet international standards.



Being a responsible member of the Indian pharma industry, Oncohiv does not work to entirely commoditize the industry so the company demands a prescription from a licensed physician before placing the order. Anyone who wants to get generic drugs from their stores requires to send them a legitimate prescription beforehand to make a successful purchase. This way, the company keeps a check on the reliability and exceptional quality of their services. The regulatory framework and infrastructure to ensure that every generic drug has been manufactured following similar quality guidelines are still not present. However, the medication offered by Oncohiv is manufactured in the WHO-approved plants which elevates the safety levels of using their drugs and OTC items.


Oncohiv has a plethora of generic drugs under its belt including medications for serious ailments like Cancer, Hepatitis B, Hepatitis C, Hodgkin's Disease, and HIV/ AIDS. The anti-cancer OTC items available at their store can be used in treating disorders like blood cancer, brain cancer, breast cancer, liver cancer, leukaemia, low platelet count, hepatic encephalopathy, prostate cancer, skin cancer, psoriasis, and thyroid cancer. They, at the same time, deals in life-saving drugs like Flacigo, Hydroxychloroquine, Ivermectin and Doxycycline along with other antibiotic medicines. In recent times, when the entire world is witnessing a global pandemic, Oncohiv has introduced some of the life-saving Covid-19 medication like Iverheal 12, Iverheal 3, Iverheal 6, Hetquenil 200mg, and Iverwon 12mg among many others to help people easily get hold of these emergency medicines.

Established in 2011, Oncohiv also takes care of the safety and privacy of their customers, which is why they ship their orders in recycled, environmentally friendly, and discreet boxes or mailers to respect people’s privacy. They have also put up a quality audit team that monitors every aspect of their production and supply chain to provide customers top-notch purchasing experience. As the government is looking forward to reducing the cost of healthcare through promoting generic medicines, Oncohiv is leading the way as a rightful torchbearer. 

 

 

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK